UNLABELLED: Mallory-Denk bodies (MDBs) are hepatocyte inclusions commonly seen in steatohepatitis. They are induced in mice by feeding 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) for 12 weeks, which also causes porphyrin accumulation. Erythropoietic protoporphyria (EPP) is caused by mutations in ferrochelatase (fch), and a fraction of EPP patients develop liver disease that is phenocopied in Fech(m1Pas) mutant (fch/fch) mice, which have an inactivating fch mutation. fch/fch mice develop spontaneous MDBs, but the molecular factors involved in their formation and whether they relate to DDC-induced MDBs are unknown. We tested the hypothesis that fch mutation creates a molecular milieu that mimics experimental drug-induced MDBs. In 13- and 20-week-old fch/fch mice, serum alkaline phosphatase, alanine aminotransferase, and bile acids were increased. The 13-week-old fch/fch mice did not develop histologically evident MDBs but manifested biochemical alterations required for MDB formation, including increased transglutaminase-2 and keratin overexpression, with a greater keratin 8 (K8)-to-keratin 18 (K18) ratio, which are critical for drug-induced MDB formation. In 20-week-old fch/fch mice, spontaneous MDBs were readily detected histologically and biochemically. Short-term (3-week) DDC feeding markedly induced MDB formation in 20-week-old fch/fch mice. Under basal conditions, old fch/fch mice had significant alterations in mitochondrial oxidative-stress markers, including increased protein oxidation, decreased proteasomal activity, reduced adenosine triphosphate content, and Nrf2 (redox sensitive transcription factor) up-regulation. Nrf2 knockdown in HepG2 cells down-regulated K8, but not K18. CONCLUSION: Fch/fch mice develop age-associated spontaneous MDBs, with a marked propensity for rapid MDB formation upon exposure to DDC, and therefore provide a genetic model for MDB formation. Inclusion formation in the fch/fch mice involves oxidative stress which, together with Nrf2-mediated increase in K8, promotes MDB formation.
UNLABELLED: Mallory-Denk bodies (MDBs) are hepatocyte inclusions commonly seen in steatohepatitis. They are induced in mice by feeding 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) for 12 weeks, which also causes porphyrin accumulation. Erythropoietic protoporphyria (EPP) is caused by mutations in ferrochelatase (fch), and a fraction of EPPpatients develop liver disease that is phenocopied in Fech(m1Pas) mutant (fch/fch) mice, which have an inactivating fch mutation. fch/fchmice develop spontaneous MDBs, but the molecular factors involved in their formation and whether they relate to DDC-induced MDBs are unknown. We tested the hypothesis that fch mutation creates a molecular milieu that mimics experimental drug-induced MDBs. In 13- and 20-week-old fch/fchmice, serum alkaline phosphatase, alanine aminotransferase, and bile acids were increased. The 13-week-old fch/fchmice did not develop histologically evident MDBs but manifested biochemical alterations required for MDB formation, including increased transglutaminase-2 and keratin overexpression, with a greater keratin 8 (K8)-to-keratin 18 (K18) ratio, which are critical for drug-induced MDB formation. In 20-week-old fch/fchmice, spontaneous MDBs were readily detected histologically and biochemically. Short-term (3-week) DDC feeding markedly induced MDB formation in 20-week-old fch/fchmice. Under basal conditions, old fch/fchmice had significant alterations in mitochondrial oxidative-stress markers, including increased protein oxidation, decreased proteasomal activity, reduced adenosine triphosphate content, and Nrf2 (redox sensitive transcription factor) up-regulation. Nrf2 knockdown in HepG2 cells down-regulated K8, but not K18. CONCLUSION:Fch/fchmice develop age-associated spontaneous MDBs, with a marked propensity for rapid MDB formation upon exposure to DDC, and therefore provide a genetic model for MDB formation. Inclusion formation in the fch/fchmice involves oxidative stress which, together with Nrf2-mediated increase in K8, promotes MDB formation.
Authors: Reginald Davies; Arenda Schuurman; Colin R Barker; Bruce Clothier; Tatyana Chernova; Fiona M Higginson; David J Judah; David Dinsdale; Richard E Edwards; Peter Greaves; Timothy W Gant; Andrew G Smith Journal: Am J Pathol Date: 2005-04 Impact factor: 4.307
Authors: Brendan M McGuire; Herbert L Bonkovsky; Robert L Carithers; Raymond T Chung; Leonard I Goldstein; John R Lake; Anna S Lok; Carol J Potter; Elizabeth Rand; Michael D Voigt; Pamela R Davis; Joseph R Bloomer Journal: Liver Transpl Date: 2005-12 Impact factor: 5.799
Authors: J C Koningsberger; L H Rademakers; J van Hattum; H B de la Faille; L J Wiegman; E Italiaander; G P van Berge Henegouwen; J J Marx Journal: J Hepatol Date: 1995-01 Impact factor: 25.083
Authors: Ikuo Nakamichi; Diana M Toivola; Pavel Strnad; Sara A Michie; Robert G Oshima; Hélène Baribault; M Bishr Omary Journal: J Cell Biol Date: 2005-12-19 Impact factor: 10.539
Authors: Athanassios Fragoulis; Julia Schenkel; Miriam Herzog; Tim Schellenberg; Holger Jahr; Thomas Pufe; Christian Trautwein; Thomas W Kensler; Konrad L Streetz; Christoph Jan Wruck Journal: Toxicol Sci Date: 2019-06-01 Impact factor: 4.849
Authors: Harvinder Saggi; Dhiman Maitra; An Jiang; Rong Zhang; Pengcheng Wang; Pamela Cornuet; Sucha Singh; Joseph Locker; Xiaochao Ma; Harry Dailey; Marc Abrams; M Bishr Omary; Satdarshan P Monga; Kari Nejak-Bowen Journal: J Hepatol Date: 2018-10-01 Impact factor: 25.083
Authors: Huabing Zhang; Sadeesh K Ramakrishnan; Daniel Triner; Brook Centofanti; Dhiman Maitra; Balázs Győrffy; Judith S Sebolt-Leopold; Michael K Dame; James Varani; Dean E Brenner; Eric R Fearon; M Bishr Omary; Yatrik M Shah Journal: Sci Signal Date: 2015-10-06 Impact factor: 8.192
Authors: Amika Singla; Nicholas W Griggs; Raymond Kwan; Natasha T Snider; Dhiman Maitra; Stephen A Ernst; Harald Herrmann; M Bishr Omary Journal: J Cell Sci Date: 2013-05-02 Impact factor: 5.285
Authors: Jared S Elenbaas; Dhiman Maitra; Yang Liu; Stephen I Lentz; Bradley Nelson; Mark J Hoenerhoff; Jordan A Shavit; M Bishr Omary Journal: FASEB J Date: 2016-02-02 Impact factor: 5.191
Authors: Yi Liu; Michael J Trnka; Shenheng Guan; Doyoung Kwon; Do-Hyung Kim; J-J Chen; Peter A Greer; A L Burlingame; Maria Almira Correia Journal: Mol Cell Proteomics Date: 2020-09-10 Impact factor: 5.911
Authors: Aniket Nikam; Jay V Patankar; Carolin Lackner; Elisabeth Schöck; Dagmar Kratky; Kurt Zatloukal; Peter M Abuja Journal: PLoS One Date: 2013-06-06 Impact factor: 3.240